RMDResMed

Health care · Medical Instruments · NYSE, OTC

We are a global leader in digital health and cloud-connected medical devices. 10-K, Item 1

Employees: 11,370
Headquarters: San Diego, CA
CEO: Michael J. Farrell
Next results: around Jan 28, 2027

Key numbers

Latest fiscal year, with ten years behind each

RevenueFY2017–26 $5.7B+9.9% Highest in 10 years 10-K FY2026 · XBRL Net incomeFY2017–26 $1.5B+8.8% Highest in 10 years 10-K FY2026 · XBRL Free cash flowFY2017–26 $1.6B−0.7% FY2025: $1.7B 10-K FY2026 · XBRL Operating marginFY2017–26 33.4%+0.6 pts 20.6% in FY2017 10-K FY2026 · XBRL

What changed

10-K filed Aug 13, 2026 against Aug 8, 2025

Area	What changed	Source
Risk factors	17 new paragraphs, nothing like them in the previous 10-K	10-K Item 1A
Auditor change	8-K item 4.01 (change in certifying accountant) filed 2026-08-17	10-K · XBRL
Accounting checks	10 other checks clear, 1 worth a look	10-K · XBRL
Insiders	No open-market buys in the last 90 days	Form 4
Filings	2 in the last 30 days	EDGAR

Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.

What's new, in their words

10-K filed Aug 13, 2026

Paragraphs in Risk Factors that were not in the 10-K filed 2025-08-08. Quoted as filed.

We are subject to new areas of direct healthcare oversight by federal government agencies due to our acquisitions of VirtuOx and Noctrix. In 2025, we acquired VirtuOx, a software-enabled independent diagnostic testing facility, or IDTF, and provider of technology solutions to facilitate in-home and remote testing services for sleep,…
10-K, Item 1A

All 17 new paragraphs →

Accounting checks

latest 10-K

10 of 11 clear 1 worth a look. Checks, not verdicts.

!
Auditor change8-K item 4.01 (change in certifying accountant) filed 2026-08-17
✓
Receivables +10.3% vs revenue +9.9% (+0.4 pts)
✓
Cash from operations $1.8B vs net income $1.5B (FY ending 2026-06-30)
✓
Inventory +2.0% vs revenue +9.9% (-7.9 pts)
✓
No statement of substantial doubt about going concern
✓
No 8-K item 4.02 in the last 2 years
✓
No NT 10-K or NT 10-Q in the last 2 years
✓
The same matters as last year: Evaluation of goodwill triggering events; PART II Item 8; RESMED INC. AND SUBSIDIARIES
✓
No sentence in the 10-K concludes that controls were not effective because of a material weakness
✓
No 8-K item 2.06 in the last 2 years
✓
No 8-K item 1.03 in the last 2 years

How each check works, with sources →

In the last 30 days

All filings →

Oct 30, 202610-Q Quarterly report (10-Q) period ended Sep 30, 2026
Oct 29, 20268-K Quarterly results, Other events 8-K items 2.02, 8.01

Get an email when this changes: new risk paragraphs, accounting items, insider purchases, a new 10-K or 10-Q. RSS feed

Work on RMD in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/RMD/export.csv") into a cell.